| abstract |
A method for treating hematological cancers using a PNP inhibitor such as forodesine in combination with an alkylating agent or an anti-CD20 agent. The application relates to the treatment of hematological cancers, which may include, for example, administration of purine nucleoside phosphorylase (PNP) inhibitors, alkylating agents, and / or anti-CD20 agents, and related compositions. And relating to the kit. Specifically, the method of the present invention comprises: (a) administering an effective amount of a (PNP) inhibitor to the subject; and (b) providing an effective amount of an alkylating agent or anti-CD20 agent to the subject. Administering. [Selection figure] None |